Evidence map›Paper›PMID 36823163›Full record

ArticleThorax2023

Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotine.

Tariq A Bhat, Suresh G Kalathil, Maciej L Goniewicz, Alan Hutson, Yasmin Thanavala

Open access · hybridAbstract read
In one paragraph

Article in Thorax, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Preclinical models of COPD: a state of the art review.The European respiratory journal · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. NAM journal · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tariq A BhatDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Suresh G KalathilDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Maciej L GoniewiczDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Alan HutsonDepartment of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Yasmin ThanavalaDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA yasmin.thanavala@roswellpark.org.
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI CANDACE S JOHNSON · 1985 to 2026
$116.6M
WNY Center for Research on Flavored Tobacco Products (CRoFT)U54CA228110 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI GONIEWICZ, MACIEJ LUKASZ · 2018 to 2022
$19.8M
Impact of novel Heat-not-Burn cigarettes on pulmonary inflammation and immunityR01HL142511 · NHLBI · ROSWELL PARK CANCER INSTITUTE CORP · PI GONIEWICZ, MACIEJ LUKASZ, THANAVALA, YASMIN · 2019 to 2021
$1.5M
NCI NIH HHS P30 CA016056NCI NIH HHS U54 CA228110NHLBI NIH HHS R01 HL142511
6 · The paper itself

Abstract

rationaleVaping has become a popular method of inhaling various psychoactive substances. While evaluating respiratory effects of vaping have primarily focused on nicotine-containing products, cannabidiol (CBD)-vaping is increasingly becoming popular. It currently remains unknown whether the health effects of vaping nicotine and cannabinoids are similar.

objectivesThis study compares side by side the pulmonary effects of acute inhalation of vaporised CBD versus nicotine.

methodsIn vivo inhalation study in mice and in vitro cytotoxicity experiments with human cells were performed to assess the pulmonary damage-inducing effects of CBD or nicotine aerosols emitted from vaping devices. MEASUREMENTS AND MAIN

resultsPulmonary inflammation in mice was scored by histology, flow cytometry, and quantifying levels of proinflammatory cytokines and chemokines. Lung damage was assessed by histology, measurement of myeloperoxidase activity and neutrophil elastase levels in the bronchoalveolar lavage fluid and lung tissue. Lung epithelial/endothelial integrity was assessed by quantifying BAL protein levels, albumin leak and pulmonary FITC-dextran leak. Oxidative stress was determined by measuring the antioxidant potential in the BAL and lungs. The cytotoxic effects of CBD and nicotine aerosols on human neutrophils and human small airway epithelial cells were evaluated using in vitro air-liquid interface system. Inhalation of CBD aerosol resulted in greater inflammatory changes, more severe lung damage and higher oxidative stress compared with nicotine. CBD aerosol also showed higher toxicity to human cells compared with nicotine.

conclusionsVaping of CBD induces a potent inflammatory response and leads to more pathological changes associated with lung injury than vaping of nicotine.

Indexed as

CannabidiolElectronic Nicotine Delivery SystemsVapingAnimalsAntioxidantsHumansLungMiceNicotineRespiratory Aerosols and DropletsAntioxidantsCannabidiolNicotineinnate immunityoxidative stress

Identifiers

PMID36823163
PMCPMC10447384
OpenAlexW4321610287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.